Click here for search results




The World Bank is involved in several TB-related working groups with some of its technical specialists participating as core members of Stop TB's TB/HIV Working Group. To learn more, please click on the links below.

STOP TB Partnership

tbThe Stop TB Partnership was established in 2000 to realize the goal of eliminating TB as a public health problem and, ultimately, to obtain a world free of TB. The World Bank has been an active member of the STOP TB Partnership including its Director of Health, Nutrition and Population serving on the STOP TB coordinating board, and additional technical specialists participating as core members of the TB/HIV working group. To learn more about the STOP TB Partnership click here.

The Global Laboratory Initiative (GLI)

WHO LogoThe Global Laboratory Initiative (GLI), formed in 2007, provides a focus for TB within a framework of a multi-faceted and integrated approach to lab strengthening through a network of partners. The GLI works closely with National TB Programmes, NGOs, technical and financial partners, and WHO offices at country and regional levels, in strengthening TB lab services. To learn more about the GLI, click here.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

gfThe Global Fund to Fight AIDS, Tuberculosis and Malaria was created to dramatically increase resources to fight three of the world's most devastating diseases. Since its founding in 2002 it has approved grants for the three diseases in excess of $10.82 billion with approximately $2.39 billion of those funds specifically for TB programs. The World Bank not only serves as the trustee for the Global Fund, but also supports the development of Global Fund proposals through the provision of technical assistance. In many countries the World Bank and the Global Fund share a common management unit for their HIV and TB projects. To learn more about the Global Fund, click here.

Tropical Disease Research

tdrThe Special Programme for Research and Training in Tropical Diseases (TDR) is an independent global programme of scientific collaboration. Established in 1975 and co-sponsored by UNICEF, UNDP, the World Bank and the WHO, it aims to help coordinate, support and influence global efforts to combat a portfolio of major diseases, including tuberculosis. For more information on TDR click here.



UNITAID is an international drug purchase facility, established to provide long-term, sustainable and predictable funding to increase access and reduce prices of quality drugs and diagnostics for the treatment of HIV/AIDS, malaria and tuberculosis in developing countries. The UNITAID Board selects project proposals which will have an impact on markets, by leveraging price reductions, encouraging the manufacture of user-friendly new products or speeding up drugs availability. To learn more about UNITAID, click here.


tdrThe United States Centers for Disease Control and Prevention’s mission is accomplished by collaborating to create the expertise, information, and tools that people and communities need to protect their health. The CDC works with partners throughout the nation and the world to monitor health, detect and investigate health problems, conduct research to enhance prevention, develop and advocate sound public health policies, implement prevention strategies, promote healthy behaviors, foster safe and healthful environments, and provide leadership and training. To learn more about CDC, click here.


Permanent URL for this page: